B. Sozeri Et Al. , "The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study," RHEUMATOLOGY INTERNATIONAL , vol.42, no.3, pp.469-475, 2022
Sozeri, B. Et Al. 2022. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study. RHEUMATOLOGY INTERNATIONAL , vol.42, no.3 , 469-475.
Sozeri, B., Ulu, K., Kaya-Akca, U., Haslak, F., Pac-Kisaarslan, A., Otar-Yener, G., ... BABA, Ö.(2022). The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study. RHEUMATOLOGY INTERNATIONAL , vol.42, no.3, 469-475.
Sozeri, Betul Et Al. "The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study," RHEUMATOLOGY INTERNATIONAL , vol.42, no.3, 469-475, 2022
Sozeri, Betul Et Al. "The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study." RHEUMATOLOGY INTERNATIONAL , vol.42, no.3, pp.469-475, 2022
Sozeri, B. Et Al. (2022) . "The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study." RHEUMATOLOGY INTERNATIONAL , vol.42, no.3, pp.469-475.
@article{article, author={Betul Sozeri Et Al. }, title={The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2022, pages={469-475} }